1[1]Aicher WK,Sakamoto KM,Hack A.A radiaton-controlled molecular switch for use in gene therapy of cancer.Gene Ther,2000,7(13):1121.
2[2]Tasi-morris CH,Cao X,Sukhetme YP.5' flanking sequence and genomic structure of Egr-1,a murine mitogen inducible zine finger encoding gene.Nucleic Acids Res,1988,16:8835.
3[3]Manome Y,Kunieda T,Wen PY et al.Transgene expression in malignant glioma using a replicative adenoviral vector containing the Egr-1 promoter:activation by ionizing radiation or uptake of radioactive iododeozyuifine.Hum Gene Ther,1998,9:1409.
5[5]Seung LP,Mauceri HJ,Beckett MA et al.Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.Cancer Res,1995,55:5561～5565.
6Black ME, Kokoris MS, Sabo P, et al. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediate tumor cell killing. Cancer Res,2001,61:3022-3026.
7Xie Y, Gibert JD, Kim JH, et al. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Clin Cancer Res, 1999,5:4224-4232.
8Freeman SM, Aboud CN, Whartenby KA, et al. The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res, 1993,53:5274-5278.
9Gnant MF, Puhlmann M, Alexander HR Jr, et al. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of surviva
